 |
| Application of immunophenotypic analysis to minimal residual disease detection in CLL: the figure shows CLL cells and normal B cells (identified by CD19 and light scatter characteristics); the normal and neoplastic cells are completely separated from each other by CD5, CD20, and CD79b expression in all patients. |